Aerovate Therapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
Aerovate Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The Company’s lead program is a drug that addresses the core disease processes of pulmonary arterial hypertension (PAH).
Company Website: https://www.aerovatetx.com